VivoSim Labs (VIVS) Share-based Compensation (2011 - 2026)
VivoSim Labs (VIVS) posted Share-based Compensation of $91000.0 for Q2 2026, up 5.81% on a QoQ basis from $86000.0 in Q1 2026, and up 16.67% year-over-year from $78000.0 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Share-based Compensation (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Share-based Compensation for 16 years, with the latest figure at $91000.0 in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 16.67% year-over-year to $91000.0 in Q2 2026; TTM through Jun 2026 was $316000.0, a 30.4% decrease from a year earlier, with the FY2026 full-year figure at $303000.0, down 43.05% from the prior year.
- Share-based Compensation was $91000.0 for Q2 2026 at VivoSim Labs, up from $86000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $872000.0 in Q1 2022, with the low at $67000.0 in Q4 2025.
- Average Share-based Compensation over 5 years is $315722.2, with a median of $156500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation surged 203.83% in 2022, then plunged 77.04% in 2024.
- Over 5 years, Share-based Compensation stood at $544000.0 in 2022, then plunged by 71.14% to $157000.0 in 2023, then declined by 17.2% to $130000.0 in 2024, then tumbled by 48.46% to $67000.0 in 2025, then surged by 35.82% to $91000.0 in 2026.
- The last three Share-based Compensation figures came in at $91000.0 (Q2 2026), $86000.0 (Q1 2026), and $67000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.35 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 18.46 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 19.78 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 12.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 7.60 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 6.25 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 530,728.82 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 201,000.00 |
| Dec 31, 2023 | 157,000.00 |
| Sep 30, 2023 | 675,000.00 |
| Jun 30, 2023 | 475,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 544,000.00 |
| Sep 30, 2022 | 673,000.00 |
| Jun 30, 2022 | 660,000.00 |
| Mar 31, 2022 | 872,000.00 |
| Dec 31, 2021 | 588,000.00 |
| Sep 30, 2021 | 426,000.00 |